[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2880807B1 - Composition pharmaceutique injectable - Google Patents

Composition pharmaceutique injectable

Info

Publication number
FR2880807B1
FR2880807B1 FR0500532A FR0500532A FR2880807B1 FR 2880807 B1 FR2880807 B1 FR 2880807B1 FR 0500532 A FR0500532 A FR 0500532A FR 0500532 A FR0500532 A FR 0500532A FR 2880807 B1 FR2880807 B1 FR 2880807B1
Authority
FR
France
Prior art keywords
pharmaceutical composition
composition injectable
injectable
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0500532A
Other languages
English (en)
Other versions
FR2880807A1 (fr
Inventor
Veronique Zanardo
Christophe Smati
Alain Botella
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Aguettant SAS
Original Assignee
Laboratoire Aguettant SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Aguettant SAS filed Critical Laboratoire Aguettant SAS
Priority to FR0500532A priority Critical patent/FR2880807B1/fr
Priority to PCT/FR2006/000095 priority patent/WO2006077309A1/fr
Publication of FR2880807A1 publication Critical patent/FR2880807A1/fr
Application granted granted Critical
Publication of FR2880807B1 publication Critical patent/FR2880807B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0500532A 2005-01-19 2005-01-19 Composition pharmaceutique injectable Expired - Fee Related FR2880807B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0500532A FR2880807B1 (fr) 2005-01-19 2005-01-19 Composition pharmaceutique injectable
PCT/FR2006/000095 WO2006077309A1 (fr) 2005-01-19 2006-01-16 Composition pharmaceutique injectable contenant une catecholamine et une hormone peptidique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0500532A FR2880807B1 (fr) 2005-01-19 2005-01-19 Composition pharmaceutique injectable

Publications (2)

Publication Number Publication Date
FR2880807A1 FR2880807A1 (fr) 2006-07-21
FR2880807B1 true FR2880807B1 (fr) 2007-04-13

Family

ID=34955408

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0500532A Expired - Fee Related FR2880807B1 (fr) 2005-01-19 2005-01-19 Composition pharmaceutique injectable

Country Status (2)

Country Link
FR (1) FR2880807B1 (fr)
WO (1) WO2006077309A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ721089A (en) * 2013-12-18 2022-10-28 The George Washington Univ A Congressional Chartered Not For Profit Corporation Angiotensin ii alone or in combination for the treatment of hypotension
UY35988A (es) * 2014-02-27 2015-09-30 Sint Sa Proceso para la producción de una solución inyectable de noradrenalina de baja concentración
WO2019182745A1 (fr) 2018-03-19 2019-09-26 Bryn Pharma, LLC Formulations pour la pulvérisation d'épinéphrine
CA3174640A1 (fr) 2020-03-06 2021-09-10 Baxter International Inc. Systeme de recipient scelle conditionne de stockage stable de formulation pharmaceutique sensible a l'oxygene

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654278A (en) * 1994-10-13 1997-08-05 Novo Nordisk A/S Composition and method comprising growth hormone and leucine
US5827893A (en) * 1996-03-29 1998-10-27 Lurie; Keith G. Mechanical and pharmacological therapies to treat cardiac arrest
JPH10298102A (ja) * 1997-04-25 1998-11-10 Taiyo Yakuhin Kogyo Kk カルシトニン注射液
JP2001233787A (ja) * 2000-02-04 2001-08-28 Patents Exploitation Co Bv 小・中サイズのペプチド含有薬学的組成物
FR2809619B1 (fr) * 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
FR2832063B1 (fr) * 2001-11-15 2004-08-27 Aguettant Lab Procede de production de solutions stables de substances phenoliques et les solutions en resultant
ITMI20021684A1 (it) * 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale

Also Published As

Publication number Publication date
FR2880807A1 (fr) 2006-07-21
WO2006077309A1 (fr) 2006-07-27

Similar Documents

Publication Publication Date Title
RU2398586C3 (ru) Фармацевтическая композиция
LTC2140867I2 (lt) Farmacinė kompozicija
BRPI0715712A2 (pt) Composição farmacêutica
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
BRPI0511900A (pt) composições farmacêuticas
BRPI0719393A2 (pt) Composição farmacêutica
DK2041139T3 (da) Farmaceutiske forbindelser
DK1957073T3 (da) Lægemiddel
DK1962873T3 (da) Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0720234A2 (pt) Composição farmacêutica
CY2014030I1 (el) Θεραπευτικες συνθεσεις που περιλαμβανουν ingenol-3-angelate
BRPI0721651A2 (pt) Composição farmacêutica
NO20075628L (no) Farmasøytiske formuleringer
DE602006020744D1 (de) Fertigspritze
DK2120884T3 (da) Farmaceutisk sammensætning
NO20055686D0 (no) Sammensetning
BRPI0611748A2 (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
MA28603B1 (fr) Composition pharmaceutique antimycobacterienne
BRPI0614413A2 (pt) composto, e, composição farmacêutica
BRPI0614412A2 (pt) composto, e, composição farmacêutica
FR2880807B1 (fr) Composition pharmaceutique injectable
ITMI20041447A1 (it) Composizione farmaceutica comprendente gabapentina
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
ITPD20050018A1 (it) Composizione insetticida

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

ST Notification of lapse

Effective date: 20190906